Literature DB >> 8109945

In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.

P French1, E Venuti, H S Fraimow.   

Abstract

Sixty strains of vancomycin- and ampicillin-resistant Enterococcus faecium were evaluated for their susceptibilities to novobiocin in vitro. In Mueller-Hinton broth, novobiocin inhibited all strains when it was used at a concentration of < or = 2 microgram/ml and 40 of 60 strains when it was used at a concentration of < or = 0.5 micrograms/ml. MICs were 8- to 16-fold higher in 50% serum. Novobiocin alone resulted in 2-log-unit killing at 24 h. Combinations of novobiocin and a fluoroquinolone (either ciprofloxacin or ofloxacin) were additive and bactericidal for quinolone-susceptible strains in either broth or 50% serum. Gentamicin did not affect novobiocin activity, and rifampin and doxycycline were antagonistic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8109945      PMCID: PMC192796          DOI: 10.1128/AAC.37.12.2736

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Novobiocin; serum concentrations and urinary excretion following oral administration in man.

Authors:  W W WRIGHT; L E PUTNAM; H WELCH
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1956-05

2.  Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.

Authors:  E G Arathoon; J R Hamilton; C E Hench; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

3.  Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.

Authors:  G L Drusano; R J Townsend; T J Walsh; A Forrest; E J Antal; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  The binding of antibiotics to serum proteins.

Authors:  G N Rolinson; R Sutherland
Journal:  Br J Pharmacol Chemother       Date:  1965-12

Review 5.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  Studies on protein binding of antibiotics. IV. Effect of the binding of drug to 100,000 X g supernatant fluid of rabbit liver homogenates on urinary excretion.

Authors:  Y Watanabe; R Kitayama; T Hayashi; Y Nakashima; M Noguchi; T Yasuda; I Saikawa; K Shimizu
Journal:  J Antibiot (Tokyo)       Date:  1982-11       Impact factor: 2.649

7.  Should novobiocin be clinically re-evaluated?

Authors:  R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jul-Aug       Impact factor: 2.803

8.  Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.

Authors:  T J Walsh; F Auger; B A Tatem; S L Hansen; H C Standiford
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

9.  A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.

Authors:  J P Eder; C A Wheeler; B A Teicher; L E Schnipper
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

10.  In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.

Authors:  D F Sahm; G T Koburov
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

View more
  4 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.

Authors:  Neil R Stokes; Helena B Thomaides-Brears; Stephanie Barker; James M Bennett; Joanne Berry; Ian Collins; Lloyd G Czaplewski; Vicki Gamble; Paul Lancett; Alastair Logan; Christopher J Lunniss; Hilary Peasley; Stéphanie Pommier; Daniel Price; Carol Smee; David J Haydon
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

4.  Properties of the strains Enterococcus haemoperoxidus and E. moraviensis, new species among enterococci.

Authors:  A Lauková; P Svec; V Strompfová; V Stĕtina; I Sedlácek
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.